Shamsuddin Anwar

Ursodiol as Salvage Therapy in Steroid- and MMF-Refractory Cholestatic Immune Checkpoint Inhibitor Hepatitis with Concurrent Pneumonitis

Uday Sankar Akash Vankayala, Mohammed Quader Naseer, Ali Sohail, Bivin George, Yashna Singh, Shamsuddin Anwar, Geetika Goyal & Ojas Balaji · Asian Journal of Medicine and Health · 2026

Introduction: Immune checkpoint inhibitor hepatitis (ICIH) occurs in 0-30% of patients receiving PD-L1 and CTLA-4 inhibitors, while checkpoint inhibitor pneumonitis (CIP) affects 2-19% of patients. ICIH typically presents as steroid-responsive hepatocellular injury. Cholestatic a...